临床医药文献电子杂志
臨床醫藥文獻電子雜誌
림상의약문헌전자잡지
Journal of Clinical Medical Literature (ElectronicEdition)
2014年
5期
659-659,661
,共2页
非小细胞肺癌%典消肿靶向疗法%复方苦参注射液
非小細胞肺癌%典消腫靶嚮療法%複方苦參註射液
비소세포폐암%전소종파향요법%복방고삼주사액
Non small cell lung cancer%Code of detumescence and targeted therapy%Compound matrine injection
本文通过探讨典消肿疗法联合复方苦参注射液治疗非小细胞肺癌的临床疗效，进而得出结论典消肿疗法联合复方苦参注射液对非小细胞肺癌进行治疗的疗效确切，延长患者生存时间，值得临床推广应用。
本文通過探討典消腫療法聯閤複方苦參註射液治療非小細胞肺癌的臨床療效，進而得齣結論典消腫療法聯閤複方苦參註射液對非小細胞肺癌進行治療的療效確切，延長患者生存時間，值得臨床推廣應用。
본문통과탐토전소종요법연합복방고삼주사액치료비소세포폐암적림상료효，진이득출결론전소종요법연합복방고삼주사액대비소세포폐암진행치료적료효학절，연장환자생존시간，치득림상추엄응용。
In this paper, by discussing the clinical effect of classic swelling therapy combined with compound matrine injection in the treatment of non small cell lung cancer, then draws the conclusion: the typical swelling therapy combined with Compound Kushen Injection in non-small cell lung cancer treatment efifcacy, prolong the survival time of patients, worthy of clinical application.
